BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34686945)

  • 1. Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis.
    Salonen J; Kreus M; Lehtonen S; Vähänikkilä H; Purokivi M; Kaarteenaho R
    Inflammation; 2022 Apr; 45(2):768-779. PubMed ID: 34686945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.
    Andersson CK; Andersson-Sjöland A; Mori M; Hallgren O; Pardo A; Eriksson L; Bjermer L; Löfdahl CG; Selman M; Westergren-Thorsson G; Erjefält JS
    Respir Res; 2011 Oct; 12(1):139. PubMed ID: 22014187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis.
    Cha SI; Chang CS; Kim EK; Lee JW; Matthay MA; Golden JA; Elicker BM; Jones K; Collard HR; Wolters PJ
    Histopathology; 2012 Jul; 61(1):98-106. PubMed ID: 22394225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
    Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
    Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
    Wygrecka M; Dahal BK; Kosanovic D; Petersen F; Taborski B; von Gerlach S; Didiasova M; Zakrzewicz D; Preissner KT; Schermuly RT; Markart P
    Am J Pathol; 2013 Jun; 182(6):2094-108. PubMed ID: 23562441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary Fibrosis.
    Aussedat PH; Chebib N; Ahmad K; Glerant JC; Drevet G; Grima R; Maury JM; Nasser M; Thivolet-Bejui F; Traclet J; Turquier S; Chalabreysse L; Tronc F; Cottin V
    Respiration; 2020; 99(12):1101-1108. PubMed ID: 33260187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Siddhuraj P; Jönsson J; Alyamani M; Prabhala P; Magnusson M; Lindstedt S; Erjefält JS
    Front Immunol; 2022; 13():924244. PubMed ID: 35983043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis.
    Oda K; Ishimoto H; Yamada S; Kushima H; Ishii H; Imanaga T; Harada T; Ishimatsu Y; Matsumoto N; Naito K; Yatera K; Nakazato M; Kadota J; Watanabe K; Kohno S; Mukae H
    Respir Res; 2014 Sep; 15(1):109. PubMed ID: 25176016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
    Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
    Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
    Papiris SA; Tomos IP; Karakatsani A; Spathis A; Korbila I; Analitis A; Kolilekas L; Kagouridis K; Loukides S; Karakitsos P; Manali ED
    Cytokine; 2018 Feb; 102():168-172. PubMed ID: 28847533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Xie T; Han L; Chen Y; Wu H
    Lung; 2021 Oct; 199(5):467-473. PubMed ID: 34462814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis.
    Tomassetti S; Wells AU; Costabel U; Cavazza A; Colby TV; Rossi G; Sverzellati N; Carloni A; Carretta E; Buccioli M; Tantalocco P; Ravaglia C; Gurioli C; Dubini A; Piciucchi S; Ryu JH; Poletti V
    Am J Respir Crit Care Med; 2016 Apr; 193(7):745-52. PubMed ID: 26562389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
    Collard HR; Calfee CS; Wolters PJ; Song JW; Hong SB; Brady S; Ishizaka A; Jones KD; King TE; Matthay MA; Kim DS
    Am J Physiol Lung Cell Mol Physiol; 2010 Jul; 299(1):L3-7. PubMed ID: 20418386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy.
    Parambil JG; Myers JL; Ryu JH
    Chest; 2005 Nov; 128(5):3310-5. PubMed ID: 16304277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expiratory Computed Tomography Density Reveals Possible Abnormalities in Radiologically Preserved Lung Parenchyma in Idiopathic Pulmonary Fibrosis.
    Petroulia V; Funke M; Zumstein P; Berezowska S; Ebner L; Geiser T; Torbica N; Heverhagen J; Poellinger A
    Invest Radiol; 2018 Jan; 53(1):45-51. PubMed ID: 28817393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of IPF has systemic consequences with multiple organ injury, with SRA
    Emura I; Usuda H
    BMC Pulm Med; 2016 Nov; 16(1):138. PubMed ID: 27809827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.